Showing 2121-2130 of 3260 results for "".
DermwireTV — Sun Rises, ICD-10 is Delayed…Again
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-sun-rises-icd-10-is-delayed-again/19139/In this week's DermwireTV, Sun acquires Ranbaxy, ICD-10 gets unexpectedly delayed, and Murad Alam recaps the ASLMS conference.Complications of Biologic Therapy for Psoriasis: Part II
https://practicaldermatology.com/topics/psoriasis/complications-of-biologic-therapy-for-psoriasis-part-ii/22039/Therapeutic success requires clinicians to understand emerging and established safety concerns.Diet and Inflammation in Dermatology
https://practicaldermatology.com/topics/other-dermatitis/diet-and-inflammation-in-dermatology/23008/PRP for Scarring Hair Disorders: Thoughts on Patient Care
https://practicaldermatology.com/topics/hair-nails/prp-for-scarring-hair-disorders-thoughts-on-patient-care/23231/Pearls for supporting patients and implementing PRP in practice.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20654/Systemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.Natural Products that Exhibit Antifungal Activity
https://practicaldermatology.com/topics/general-topics/natural-products-that-exhibit-antifungal-activity/20360/Can natural products fight the fungus among us?Overcoming Dr. Google: The Rise in Questionable Self-Diagnostics and Disinformation
https://practicaldermatology.com/topics/practice-management/overcoming-dr-google-the-rise-in-questionable-self-diagnostics-and-disinformation/23993/Combatting the social media and influencers who play an outsized role in the spread of questionable or bad medical information.Currents: Diversity In Dermatology
https://practicaldermatology.com/topics/skin-of-color/currents-diversity-in-dermatology/23760/DermwireTV — Valeant Ups Allergan Bid, Nestle Buys Injectables, and Allergan Makes Its Case
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-mdash-valeant-ups-allergan-bid-nestle-buys-injectables-and-allergan-makes-its-case/19128/BREAKING NEWS: Valeant has increased its offer for Allergan to $72 per share. Read more. Valeant sells the rights to its aesthetic injectables to Nestle, while Allergan touts physician support and challenges Valeant's business model. In this week's edition of DermWireTV, learn about Valeant's lates